Cancer
Neoplasm of Uncertain Histogenesis
CI-CAN-00000034Explore in graph →
Non-malignant20,291 active trials259 approved drugs3,814 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00000034Explore in graph →
Clinical trials
91,377 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04799548 | A Phase II Study of TACE Plus PD-1 Antibody in the Locally Advanced Stomach Adenocarcinoma | unknown | Phase 2 | 71 | Shanghai Zhongshan HospitalOTHER | 1 | May 23, 2024 | clinicaltrials |
| NCT05878028 | L-TIL Plus Tislelizumab for PD1 Antibody Resistant aNSCLC | unknown | Phase 2 | 33 | Quanli GaoOTHER_GOV | 1 | May 23, 2024 | clinicaltrials |
| NCT06227156 |
| Disitamab Vedotin in the Treatment With HER2- Expression, Subjects With Locally Advanced or Metastatic Castration-resistant Prostate Cancer |
| unknown |
| Phase 2 |
| 40 |
| RemeGen Co., Ltd.INDUSTRY |
| 1 |
| May 23, 2024 |
| clinicaltrials |
| NCT06424379 | BCL6-rearrangements Implications in Non-Hodgkin Lymphomas.(BCL6-RINHL) | unknown | — | 135 | Hospices Civils de LyonOTHER | 1 | May 23, 2024 | clinicaltrials |
| NCT06427291 | Clinical Study of T3011 Intravesical Instillation for Treatment of NMIBC Patients | unknown | Phase 1 | 20 | Fudan UniversityOTHER | 1 | May 23, 2024 | clinicaltrials |
| NCT03724500 | Clinical Significance of Circulating Tumor Cell in Non Small Cell Lung Cancer | unknown | — | 65 | Chang Gung Memorial HospitalOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT05386225 | Individualized Follow-Up for Head and Neck Cancer(INFLUENCE) | unknown | — | 210 | Radboud University Medical CenterOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT05483712 | Brass Mesh Bolus in Rotational Post-Mastectomy Radiation Therapy | unknown | N/A | 20 | Nova Scotia Cancer CentreOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT05622162 | Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7(MIP7) | unknown | Phase 3 | 106 | ITEL Telecomunicazioni SrlINDUSTRY | 1 | May 22, 2024 | clinicaltrials |
| NCT05984797 | Integrated Short-Term Palliative Rehabilitation in Incurable Cancer(INSPIRE) | unknown | N/A | 340 | King's College LondonOTHER | 5 | May 22, 2024 | clinicaltrials |
| NCT06417606 | Lenvatinib and Adebrelimab Combined With GEMOX in the Perioperative Treatment of Potentially Resectable Intrahepatic Cholangiocarcinoma | unknown | Phase 4 | 20 | Zhiyong HuangOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT06424821 | Cadonilimab Plus Chemotherapy as First-line Treatment for PD-L1 Negative NSCLC(LungCadX) | unknown | Phase 2 | 54 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT06424873 | Dynamic Whole-body PET/CT Imaging in Clinical Oncology(Dynamic PET/CT) | unknown | N/A | 60 | Valentina GaribottoOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT06425315 | Management of Malnutrition in Oncogeriatrics | unknown | — | 120 | Hospices Civils de LyonOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT03992456 | Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer | unknown | Phase 2 | 12 | Academic and Community Cancer Research UnitedOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT04418154 | Neoadjuvant Dose-dense EC Followed by ABX With PD-1 for Triple Negative Breast Cancer Patients(NeoTENNIS) | unknown | Phase 2 | 70 | Fudan UniversityOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT05490719 | A Phase II Study of CRT Combined With QL1706 in ESCC Patients | unknown | Phase 2 | 39 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT05955105 | A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies | unknown | Phase 1 / Phase 2 | 200 | Innolake BiopharmINDUSTRY | 1 | May 21, 2024 | clinicaltrials |
| NCT05964101 | Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma(GALAXY-1) | unknown | Phase 2 | 25 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT06278610 | Pelvic Exenteration and Laterally Extended Pelvic Resection(Pre-PEX) | unknown | — | 85 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT06422546 | A Prospective, Multicenter, Non-interventional, Real-world Study to Characterize Changes in Molecular Markers After Three Weeks of Targeted Therapy With Oxitinib in EGFRm NSCLC(pre-FLAME) | unknown | — | 950 | Beijing Cancer Prevention & Treatment SocietyOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT06423066 | Developing a Machine Learning Model to Predict Pleural Adhesion Preoperatively Using Pleural Ultrasound | unknown | — | 200 | Peking Union Medical College HospitalOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT06423144 | PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7 | unknown | — | 150 | Shanghai Zhongshan HospitalOTHER | 0 | May 21, 2024 | clinicaltrials |
| NCT06423924 | Second Primary Cancer and Early-onset Colorectal Cancer | unknown | — | 10,000 | LI XIN-XIANGOTHER | 0 | May 21, 2024 | clinicaltrials |
| NCT06421571 | The Mechanism of Action of Chlormethine (CL) Gel in the Treatment of MF-CTCL Adult Patients(GR-CTCL_CL) | unknown | — | 40 | National and Kapodistrian University of AthensOTHER | 1 | May 20, 2024 | clinicaltrials |
| NCT06421610 | OPC5: Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) in Patients With Malignant Pleural Effusion. | unknown | Phase 1 | 20 | Odense University HospitalOTHER | 1 | May 20, 2024 | clinicaltrials |
| NCT06422156 | SBRT Combined With Nimotuzumab and Mono-chemotherapy in Locally Advanced Pancreatic Cancer(Nim-PC-28) | unknown | Phase 2 | 73 | Peking University Third HospitalOTHER | 0 | May 20, 2024 | clinicaltrials |
| NCT03337087 | Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer | unknown | Phase 1 / Phase 2 | 18 | Academic and Community Cancer Research UnitedOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT04444869 | Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer(ENID) | unknown | Phase 2 | 28 | University of Missouri-ColumbiaOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT04480502 | ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma(ENVASARC) | unknown | Phase 2 | 207 | Tracon Pharmaceuticals Inc.INDUSTRY | 2 | May 17, 2024 | clinicaltrials |
| NCT04909073 | Observational Study of Afatinib 30 mg Daily | unknown | — | 69 | National University Hospital, SingaporeOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT04965129 | Supplementation of n-3 PUFA in the Modulation of Lean Mass in Patients With Lung Cancer Receiving a High-protein Diet | unknown | N/A | 50 | Universidade Federal do Rio de JaneiroOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT05065346 | Neoadjuvant DaRT for Locally Advanced Oral Cavity SCC | unknown | N/A | 79 | Alpha Tau Medical LTD.INDUSTRY | 1 | May 17, 2024 | clinicaltrials |
| NCT05189197 | A Study to Evaluate Efficacy and Safety of Zanubrutinib With R-CHOP in Newly Diagnosed Non-GCB DLBCL Patients With Double Expression | unknown | Phase 2 | 41 | Fudan UniversityOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT06261008 | Interactive Telehealth Intervention to Increase Longitudinal Adherence to Repeat Faecal Immunochemical Test Screening | unknown | N/A | 370 | Chinese University of Hong KongOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT06410716 | Comparing Valve-regulated Pleural Drainage to Traditional Closed Chest Tube Drainage | unknown | N/A | 100 | Peking Union Medical College HospitalOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT06411457 | SHR-A1811 in Combination With Adebrelimab for the Treatment of HER2 Low-expressing Metastatic Breast Cancer | unknown | Phase 2 | 20 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT06419140 | Multimodal Rehabilitation on Gastric Adenocarcinoma Patients Following Radical D2 Gastrectomy | unknown | Phase 2 | 138 | Zhejiang Cancer HospitalOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT06419244 | Myosteatosis in Oeso-gastric Cancer: Clinical Impacts | unknown | N/A | 50 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT04071964 | Gut Microbiota, Anastomotic Leak and Colorectal Cancer | unknown | — | 300 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT04672005 | Modified FOLFIRINOX Alternated With Biweekly Gemcitabine Plus Nab-Paclitaxel Untreated Pancreatic Cancer | unknown | Phase 2 | 30 | Lyudmyla BerimOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT05024318 | NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma(NAPSTER) | unknown | Phase 2 | 20 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT05233787 | Trial Evaluating the Tailored Versus the Systematic Use of Defunctioning Stoma After Total Mesorectal Excision for Rectal Cancer (GRECCAR17)(GRECCAR17) | unknown | N/A | 212 | University Hospital, BordeauxOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT05863013 | Use of the ADL-Glittre Test in the Pre and Postoperative Period of Patients With Lung Cancer | unknown | N/A | 80 | Centro Universitário Augusto MottaOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT05934864 | Different Molecular Subtypes of Peripheral T-cell Lymphoma, a Real-world Registry Study. (TRUST) | unknown | — | 1,000 | Ruijin HospitalOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT06036563 | Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing | unknown | — | 3,200 | Air Force Military Medical University, ChinaOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT06246630 | In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor | unknown | N/A | 20 | Ruijin HospitalOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT06415162 | Evaluation of the Effects of Using Cooling Pillowcases, on the Symptoms of Hot Flushes, Sleep and Life Quality | unknown | N/A | 64 | Saglik Bilimleri UniversitesiOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT06415708 | Obinutuzumab Combined With Bendamustine in the Treatment of Mature B-cell Lymphoma | unknown | Phase 2 | 134 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT06415851 | Chemotherapy Plus Bevacizumab and Anti-PD-1 Followed by Induction Therapy of Chemotherapy Plus Bevacizumab | unknown | Phase 2 | 36 | Zhangfa SongOTHER | 1 | May 16, 2024 | clinicaltrials |
Data updated 24 days agoSource updated May 23, 2024source: clinicaltrials